Release Fact’s Brian Harris recently wrote an article titled, “Eric Lefkofsky’s Tempus Labs Uses Big Data Analytics to Revolutionize Cancer Medicine”. The article discusses Chicago’s influential entrepreneur, Eric Lefkofsky, and his new enterprise Tempus Labs. The company has already claimed a spot as one of the top health tech start-ups.
Tempus collaborated with the National Cancer Institute to create one of the most comprehensive libraries of cancer testing. Not only do the sequence DNA and RNA to understand the patient’s tumors, but they also use machine learning to create an electronic medical record with information on the immune system and which treatments have worked with patients of similar backgrounds for a more personalized treatment plans.
Tempus is considered to be groundbreaking because it implements gene therapy and gene editing. These biotechnologies have an impact on diseases that were deemed untreatable before.
The machine learning provided by tempus has also been designed with an algorithm to help identify skin cancer. The program is so advanced that it is equal to a physician’s ability to identify skin cancer correctly, both benign and malignant lesions.
To help those with insulin issues, the company seeks to release an FDA approved glucose sensor that may apply the dose of insulin directly. These monitors will monitor the glucose of a patient and send the information to smart technology like their watch or iPhone.
Tempus was established in 2015 and quickly brought in $130 million in funding. Its specialty is machine learning that creates an interactive and analytical platform for physicians to create personalized treatment plans for cancer patients. The genome sequencing provided by the company allows doctors to create data-driven solutions, using information from other patients who have similar backgrounds and diagnoses. Tempus is also involved with several research universities and cancer centers.
Eric Lefkofsky is the co-founder of Tempus Labs, which he created to improve the treatment process of cancer after having personal experience with the issues after the diagnoses of a close acquaintance. He is also the co-founder of a variety of companies like Echo Global Logistics, InnerWorkings, and Groupon, causing him to become one of Chicago’s leading entrepreneurs.
About Eric Lefkofsky: www.lightbank.com/team/eric-lefkofsky